Terms: = Germ cell tumor AND FH, HLRCC, 2271, ENSG00000091483, MCUL1, MCL, LRCC, P07954 AND Clinical Outcome
9 results:
1. Molecular analysis of aggressive renal cell carcinoma with unclassified histology reveals distinct subsets.
Chen YB; Xu J; Skanderup AJ; Dong Y; Brannon AR; Wang L; Won HH; Wang PI; Nanjangud GJ; Jungbluth AA; Li W; Ojeda V; Hakimi AA; Voss MH; Schultz N; Motzer RJ; Russo P; Cheng EH; Giancotti FG; Lee W; Berger MF; Tickoo SK; Reuter VE; Hsieh JJ
Nat Commun; 2016 Oct; 7():13131. PubMed ID: 27713405
[TBL] [Abstract] [Full Text] [Related]
2. Hypoxia-Inducible Factor 2α Mutation-Related Paragangliomas Classify as Discrete Pseudohypoxic Subcluster.
Fliedner SM; Shankavaram U; Marzouca G; Elkahloun A; Jochmanova I; Daerr R; Linehan WM; Timmers H; Tischler AS; Papaspyrou K; Brieger J; de Krijger R; Breza J; Eisenhofer G; Zhuang Z; Lehnert H; Pacak K
Neoplasia; 2016 Sep; 18(9):567-76. PubMed ID: 27659016
[TBL] [Abstract] [Full Text] [Related]
3. Histological criteria for grading of atypia in melanocytic conjunctival lesions.
Maly A; Epstein D; Meir K; Pe'er J
Pathology; 2008 Dec; 40(7):676-81. PubMed ID: 18985522
[TBL] [Abstract] [Full Text] [Related]
4. mcl-1 expression in gestational trophoblastic disease correlates with clinical outcome: a differential expression study.
Fong PY; Xue WC; Ngan HY; Chan KY; Khoo US; Tsao SW; Chiu PM; Man LS; Cheung AN
Cancer; 2005 Jan; 103(2):268-76. PubMed ID: 15578716
[TBL] [Abstract] [Full Text] [Related]
5. TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.
Shimada H; Nakagawa A; Peters J; Wang H; Wakamatsu PK; Lukens JN; Matthay KK; Siegel SE; Seeger RC
Cancer; 2004 Oct; 101(8):1873-81. PubMed ID: 15386308
[TBL] [Abstract] [Full Text] [Related]
6. Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
Goto S; Umehara S; Gerbing RB; Stram DO; Brodeur GM; Seeger RC; Lukens JN; Matthay KK; Shimada H
Cancer; 2001 Nov; 92(10):2699-708. PubMed ID: 11745206
[TBL] [Abstract] [Full Text] [Related]
7. Relationship between histopathological features, MYCN amplification, and prognosis: a UKCCSG study. United Kingdom Children Cancer Study Group.
George RE; Variend S; Cullinane C; Cotterill SJ; McGuckin AG; Ellershaw C; Lunec J; Pearson AD;
Med Pediatr Oncol; 2001 Jan; 36(1):169-76. PubMed ID: 11464876
[TBL] [Abstract] [Full Text] [Related]
8. Pathology review of screening negative neuroblastomas: a report from the Quebec Neuroblastoma Screening Project.
Kawakami T; Monobe Y; Monforte H; Woods WG; Tuchman M; Lemieux B; Brisson L; Bernstein M; Brossard J; Leclerc JM; Byrne TD; Triche TJ; Shimada H
Cancer; 1998 Aug; 83(3):575-81. PubMed ID: 9690552
[TBL] [Abstract] [Full Text] [Related]
9. BCL-2 family protein expression in human malignant glioma: a clinical-pathological correlative study.
Rieger L; Weller M; Bornemann A; Schabet M; Dichgans J; Meyermann R
J Neurol Sci; 1998 Feb; 155(1):68-75. PubMed ID: 9562325
[TBL] [Abstract] [Full Text] [Related]
